Name | PF-956980 |
---|---|
Synonyms |
((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)(pyrrolidin-1-yl)methanone
Methanone, [(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-1-pyrrolidinyl- {(3R,4R)-4-Methyl-3-[methyl(1H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}(1-pyrrolidinyl)methanone |
Description | PF-00956980 is a reversible pan-JAK inhibitor with IC50 values of 2.2, 23.1 and 59.9 μM for JAK1, JAK2 and JAK3, respectively. PF-00956980 can be used in the research of lung and skin inflammatory diseases[1]. |
---|---|
Related Catalog | |
Target |
JAK1:2.2 μM (IC50) JAK2:23.1 μM (IC50) JAK3:59.9 μM (IC50) |
In Vivo | The pharmacokinetic parameters of PF-00956980(compound 2) in rat or dog Spesies Dose (mg/kg) Cl (mL/min/Kg) Clunbound (mL/min/Kg) Vss (L/Kg) Terminal T1/2 (h) Oral Bioavailability Rat i.v. 0.5 48 >48,000 0.8 2.1 - Rat p.o. 1 - - - - <5% Dog i.v. 0.1 18 >18,000 1.0 2.0 - |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Molecular Formula | C18H26N6O |
Molecular Weight | 342.439 |
Exact Mass | 342.216797 |
LogP | 2.35 |
Index of Refraction | 1.658 |
Storage condition | Store at -20°C |